GlassScriptPhysician profile
Jorge Mercado
NPI 1447411970
$26,690.14
in general payments reported to CMS, 2019-2025
30 companies · $6,098 in 2025
The $6,098 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $1,047 · 2021: $3,407 · 2022: $3,464 · 2023: $10K · 2024: $1,817 · 2025: $6,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,640 · Consulting Fee: $5,808 · Education: $4,316 · Travel and Lodging: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,640.41 |
| Consulting Fee | $5,807.50 |
| Education | $4,315.91 |
| Travel and Lodging | $1,283.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $7,377.10 | 2019-2025 | Monarch Platform |
| Intuitive Surgical, INC. | $4,773.53 | 2019-2025 | |
| Medical Device Business Services, INC. | $3,739.21 | 2023-2024 | Monarch Platform, Monarch |
| Noah Medical Corporation | $2,807.43 | 2023-2025 | Galaxy |
| Advanced Respiratory, INC | $1,795.68 | 2020-2021 | |
| Galvanize Therapeutics, INC | $846.75 | 2023-2025 | Aliya System |
| Genzyme Corporation | $742.37 | 2021-2025 | |
| Genentech USA, INC. | $510.89 | 2019-2025 | Xolair |
| Pentax of America, INC. | $500.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $457.31 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Jascayd |
| Glaxosmithkline, LLC. | $449.40 | 2021-2025 | Shingrix, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $371.11 | 2021-2025 | Breztri, Tezspire |
| Regeneron Healthcare Solutions, INC. | $330.88 | 2021-2025 | Dupixent |
| Body Vision Medical INC. | $314.87 | 2023 | Lungvision |
| Actelion Pharmaceuticals US, INC. | $243.97 | 2022-2025 | Opsumit, Uptravi |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $167.84 | 2023-2024 | Spiration Valve System |
| Jazz Pharmaceuticals INC. | $150.00 | 2025 | |
| Amgen INC. | $141.91 | 2021-2025 | Tezspire |
| Ambu INC. | $125.00 | 2023 | |
| Verona Pharma, INC. | $120.25 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $114.98 | 2019 | |
| Philips North America LLC | $114.51 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Baxter Healthcare | $109.97 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $93.82 | 2023 | Yupelri |
| Insmed, INC. | $91.23 | 2020 | |
| Sanofi-Aventis U.S. LLC | $66.99 | 2025 | |
| Electromed, INC. | $61.77 | 2025 | Smartvest |
| Pfizer INC. | $31.05 | 2023-2024 | |
| Abbvie INC. | $22.99 | 2023 | |
| Grifols USA, LLC | $17.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.